0001708138-21-000082.txt : 20210915 0001708138-21-000082.hdr.sgml : 20210915 20210915160354 ACCESSION NUMBER: 0001708138-21-000082 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210913 FILED AS OF DATE: 20210915 DATE AS OF CHANGE: 20210915 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BROWN MICHAEL S CENTRAL INDEX KEY: 0001174475 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 211255454 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-09-13 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001174475 BROWN MICHAEL S 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2021-09-13 4 M 0 2479 380.95 A 3370 D Common Stock 2021-09-13 4 M 0 3613 413.33 A 6983 D Common Stock 2021-09-13 4 M 0 3612 413.33 A 10595 D Common Stock 2021-09-13 4 S 0 100 636.74 D 10495 D Common Stock 2021-09-13 4 S 0 200 637.29 D 10295 D Common Stock 2021-09-13 4 S 0 676 638.64 D 9619 D Common Stock 2021-09-13 4 S 0 203 639.2 D 9416 D Common Stock 2021-09-13 4 S 0 100 640.77 D 9316 D Common Stock 2021-09-13 4 S 0 100 641.12 D 9216 D Common Stock 2021-09-13 4 S 0 400 642.62 D 8816 D Common Stock 2021-09-13 4 S 0 100 643.49 D 8716 D Common Stock 2021-09-13 4 S 0 100 644.89 D 8616 D Common Stock 2021-09-13 4 S 0 100 645.66 D 8516 D Common Stock 2021-09-13 4 S 0 100 646.28 D 8416 D Common Stock 2021-09-13 4 S 0 151 647.58 D 8265 D Common Stock 2021-09-13 4 S 0 962 648.48 D 7303 D Common Stock 2021-09-13 4 S 0 838 649.46 D 6465 D Common Stock 2021-09-13 4 S 0 1800 650.4 D 4665 D Common Stock 2021-09-13 4 S 0 3712 651.1 D 953 D Common Stock 2021-09-13 4 S 0 62 652.26 D 891 D Common Stock 5000 I by SLAT Common Stock 7662 I by Trust Non-Qualified Stock Option (right to buy) 380.95 2021-09-13 4 M 0 2479 0.0 D 2028-01-02 Common Stock 2479 0 D Non-Qualified Stock Option (right to buy) 413.33 2021-09-13 4 M 0 3613 0.0 D 2025-01-02 Common Stock 3613 3612 D Non-Qualified Stock Option (right to buy) 413.33 2021-09-13 4 M 0 3612 0.0 D 2025-01-02 Common Stock 3612 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 200 shares of Company stock on September 13, 2021 at prices ranging from $637.20 to $637.37. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price. Represents volume-weighted average price of sales of 676 shares of Company stock on September 13, 2021 at prices ranging from $638.16 to $638.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price. Represents volume-weighted average price of sales of 203 shares of Company stock on September 13, 2021 at prices ranging from $639.09 to $639.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price. Represents volume-weighted average price of sales of 400 shares of Company stock on September 13, 2021 at prices ranging from $642.36 to $642.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price. Represents volume-weighted average price of sales of 151 shares of Company stock on September 13, 2021 at prices ranging from $647.42 to $647.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price. Represents volume-weighted average price of sales of 962 shares of Company stock on September 13, 2021 at prices ranging from $648.30 to $648.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price. Represents volume-weighted average price of sales of 838 shares of Company stock on September 13, 2021 at prices ranging from $649.00 to $649.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price. Represents volume-weighted average price of sales of 1,800 shares of Company stock on September 13, 2021 at prices ranging from $650.19 to $650.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price. Represents volume-weighted average price of sales of 3,712 shares of Company stock on September 13, 2021 at prices ranging from $651.10 to $651.21. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price. These shares are held in a trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. /s/**Michael S. Brown 2021-09-15